Ignite Creation Date:
2025-12-24 @ 7:48 PM
Ignite Modification Date:
2026-03-20 @ 3:26 AM
Study NCT ID:
NCT06651203
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-10-21
First Post:
2024-10-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of the KIR3DL2 Marker in Flow Cytometry for Sézary Syndrome Diagnosis, Therapeutic Response and Residual Disease: a Prospective and Multicenter Study
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
APHP220915
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None